OMNARIS 50 MCG — DIN 02303671
CICLESONIDE : 50 MCG · COVIS PHARMA GMBH · SPRAY, METERED DOSE · wholesale supply in Canada
Health Canada status: MARKETED
What is OMNARIS?
OMNARIS 50 MCG contains CICLESONIDE : 50 MCG. It is listed in the Health Canada Drug Product Database under DIN 02303671, held by COVIS PHARMA GMBH, supplied as SPRAY, METERED DOSE for NASAL administration. Health Canada currently lists it as marketed, status dated 11-Aug-2022. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is OMNARIS used for?
Treatment of seasonal allergic rhinitis (including hayfever) and perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
How much does Ciclesonide cost around the world?
Ciclesonide is listed on 8 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.
What a market publishes matters more than the number it publishes. Australia publishes a ex-manufacturer; Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory). Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.
| Market | Price basis published there | Brands | Packs listed | Range |
|---|---|---|---|---|
| South Africa | single exit price | 5 | 8 | ZAR███.██ |
| Italy | prezzo al pubblico (classe A) | 5 | 5 | EUR███.██ |
| Australia | ex-manufacturer | 2 | 4 | AUD███.██ |
| Czechia | max producer price (ex-factory) | 2 | 3 | CZK███.██ |
| United Kingdom | hospital | 3 | 3 | GBP███.██ |
| Greece | producer price (ex-factory) | 3 | 3 | EUR███.██ |
| Saudi Arabia | public | 2 | 3 | SAR███.██ |
| Austria | KVP (Kassenverkaufspreis) | 2 | 2 | EUR███.██ |
31 pack listings across 24 brand entries and 8 price bases, refreshed 08 Sep 2026. Ranges span every Ciclesonide pack in that market, so a high figure is usually a larger pack rather than the same product.
Canada publishes no comparable public list price. For a delivered Canadian price on a licensed account, verify your licence — it takes about a minute.
Is there a generic Ciclesonide in Canada, and who makes it?
Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.
3 holders have a Canadian DIN containing Ciclesonide, across 3 DINs, of which 1 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.
| Market authorization holder | DINs | Marketed | Brand names | Position |
|---|---|---|---|---|
| COVIS PHARMA GMBH | 1 | 1 | OMNARIS | Sourceable in Canada |
| APOTEX INC | 1 | 0 | APO-CICLESONIDE | No marketed DIN |
| TAKEDA CANADA INC | 1 | 0 | OMNARIS HFA | No marketed DIN |
Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.
How is it supplied and stored?
Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.
| Strength on the label | 50 MCG |
|---|---|
| Dosage form | SPRAY, METERED DOSE |
| Route | NASAL |
| Pack configuration (monograph) | Amber glass bottle in a protective plastic sleeve. Available in 120-metered sprays (12.5 g fill) and 60-metered sprays (7.1 g fill). |
| Storage | Store at room temperature (15–30°C). Do not freeze. Store in foil pouch until first use. Discard 4 months after removal from pouch. |
Before an order line is unambiguous Nexara needs the strength, the pack size and the presentation, because this listing covers more than one of them.
Substance and classification
| Active substance | Ciclesonide |
|---|---|
| ATC code | R01AD13 |
| AHFS class | 28:16.08.04 |
| Biosimilar biologic | No |
Health Canada record and identifiers
The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.
| DIN (8-digit, as used in ordering) | 02303671 |
|---|---|
| DIN (unpadded, as printed on some documents) | 2303671 |
| Brand name | OMNARIS |
| Generic / active ingredient | CICLESONIDE : 50 MCG |
| Market authorization holder | COVIS PHARMA GMBH |
| Health Canada schedule | Prescription |
| ATC code | R01AD13 |
| ATC anatomical main group | R — Respiratory system |
| ATC therapeutic subgroup | R01AD |
| Current status | MARKETED |
| Status date | 11-Aug-2022 |
| Original market date | 2007-12-21 00:00:00 |
| Status source | Live Health Canada DPD sync |
Verify on the primary sources
How is it administered?
Adults and Adolescents (12+): 200 mcg per day (2 sprays in each nostril once daily). Prime pump 8 times before first use. Shake gently before use.
Included because it drives pack selection and wastage. Consult the monograph.
Contraindications
Hypersensitivity to any of the ingredients. Use with caution, if at all, in patients with active or quiescent tuberculosis infections of the respiratory tract.
Warnings and precautions
Risk of nasal septal perforation, Candida infections, and impaired wound healing. Monitor for systemic corticosteroid effects (hypercorticism, adrenal suppression) and growth in adolescents.
What can be used instead?
Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.
1 · Same molecule, other Canadian presentations
1 of 3 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.
| Product | Strength | Form | Holder | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-CICLESONIDE | 50 MCG | SPRAY, METERED DOSE | APOTEX INC | DORMANT | 02417316 |
| OMNARIS HFA | 50 MCG | AEROSOL, METERED DOSE | TAKEDA CANADA INC | CANCELLED POST MARKET | 02404311 |
2 · Same class — other molecules in ATC R01AD
| Molecule | Canadian brands | DINs | Marketed | Sourceable |
|---|---|---|---|---|
| Mometasone | APO-MOMETASONE · MOMETASONE · MOSASPRAY · NASAL ALLERGY AND CONGESTION RELIEF · NASONEX · NASONEX ALLERGY AND CONGESTION · SANDOZ MOMETASONE · TEVA-MOMETASONE | 9 | 6 | Yes |
| Fluticasone | 24HR NASAL ALLERGY RELIEF · ALLERGY RELIEF NASAL SPRAY · APO-FLUTICASONE · FLONASE - AEM-SUS NAS 50MCG/MD · FLONASE AEM-SUS 50MCG/AEM · FLONASE ALLERGY RELIEF · NU-FLUTICASONE · RATIO-FLUTICASONE · TEVA-FLUTICASONE | 9 | 4 | Yes |
| Budesonide | MYLAN-BUDESONIDE AQ · RHINOCORT AQUA · RHINOCORT AQUA 100MCG · RHINOCORT TURBUHALER 100 MCG/DOSE | 5 | 3 | Yes |
| Triamcinolone | APO-TRIAMCINOLONE AQ · NASACORT · NASACORT ALLERGY 24HR · NASACORT AQ · NASAL SPRAY ALLERGY 24HR | 5 | 3 | Yes |
| Fluticasone, Combinations | APO-AZELASTINE/FLUTICASONE · DYMISTA · MYLAN-AZELASTINE/FLUTICASONE | 3 | 3 | Yes |
| Beclomethasone | APO-BECLOMETHASONE NASAL SPRAY · BECLOMETHASONE AQUEOUS NASAL SPRAY 50MCG/METERED DOSE · BECLOMETHASONE DIPROPIONATE NAS-SPR 50MCG/AEM · BECLOMETHASONE DIPROPIONATE NASAL INHALER · BECLOMETHASONE NASAL SPRAY · BECONASE AQ NASAL AEM 50MCG/AEM · BECONASE NASAL AEM 50MCG/AEM · MYLAN-BECLO AQ · QNASL · RATIO-BECLOMETHASONE AQ · RIVANASE AQ.NASAL SPRAY 50MCG/METERED DOSE · VANCENASE AER 50MCG | 13 | 2 | Yes |
| Ciclesonide | APO-CICLESONIDE · OMNARIS · OMNARIS HFA | 3 | 1 | Yes |
| Fluticasone Furoate | AVAMYS | 1 | 1 | Yes |
| Mometasone, Combinations | RYALTRIS | 1 | 1 | Yes |
| Flunisolide | APO-FLUNISOLIDE NASAL SPRAY · NOVO-FLUNISOLIDE · PMS-FLUNISOLIDE · RATIO-FLUNISOLIDE · RHINALAR · RHINALAR NASAL MIST | 6 | 0 | Not in Canada |
A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.
3 · Adjacent classes in ATC R01A
| ATC subgroup | Molecules | DINs | Marketed |
|---|---|---|---|
| R01AA | Ephedrine · Oxymetazoline · Phenylephrine · Xylometazoline | 76 | 18 |
| R01AX | Combinations · Ipratropium Bromide · Various | 42 | 4 |
| R01AB | Ephedrine · Naphazoline · Oxymetazoline · Phenylephrine | 12 | 1 |
| R01AC | Cromoglicic Acid · Levocabastine | 6 | 0 |
Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.
What else is OMNARIS called?
The same molecule, Ciclesonide, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:
| Name | Script | Registered in |
|---|---|---|
| ALVESCO | Latin | Czechia |
| CICLESONIDE GLENMARK | Latin | Czechia |
| Omnair® | Latin | South Africa |
Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Why is there no price on this page?
Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.